Growth Metrics

Baxter International (BAX) Receivables (2016 - 2025)

Baxter International (BAX) has disclosed Receivables for 17 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Receivables rose 10.4% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, up 10.4% year-over-year, with the annual reading at $1.8 billion for FY2025, 10.4% up from the prior year.
  • Receivables for Q4 2025 was $1.8 billion at Baxter International, up from $1.8 billion in the prior quarter.
  • The five-year high for Receivables was $2.7 billion in Q4 2022, with the low at $1.6 billion in Q1 2025.
  • Average Receivables over 5 years is $2.2 billion, with a median of $2.3 billion recorded in 2021.
  • The sharpest move saw Receivables soared 38.14% in 2021, then crashed 37.89% in 2023.
  • Over 5 years, Receivables stood at $2.5 billion in 2021, then grew by 10.64% to $2.7 billion in 2022, then plummeted by 37.89% to $1.7 billion in 2023, then dropped by 1.88% to $1.7 billion in 2024, then increased by 10.4% to $1.8 billion in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $1.8 billion, $1.8 billion, and $1.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.